NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Salient Bio

Salient Bio

Private
LondonHealthcare & Life Scienceshttps://salient.bio/

Last Round

Seed

Sep 3, 2025

Total Funding Raised

$3.15M

Company Overview

Salient Bio is a biotechnology company that operates a diagnostic laboratory and develops non-invasive diagnostic tests by integrating synthetic biology, robotics, and microbiome metagenomics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

microbiome testingdiagnostic laboratoryprecision medicinemetagenomicsbioinformaticsclinical diagnosticsdigital healthAPI integrationsynthetic biologymolecular diagnosticslab-as-a-servicegut health testingmedical AIbiotech infrastructureLIMS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Salient Bio Comparables

Compare Salient Bio with similar companies based on industry and business-model similarity.

Salient Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Salient Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 3, 2025

Salient Bio Investors

Notable investors and investment history

Salient Bio investors
InvestorRounds
THENA CapitalSeed

Salient Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Salient Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Salient Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range20
Year Founded2020
Last FundingSep 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.